BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24135250)

  • 1. Association between clinical pathology and multiple genes mRNA expression in Chinese patients with NSCLC.
    Chen G; Jundong GU; Chen J; Liu Y; Song Z
    J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S98-100. PubMed ID: 24135250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.
    Cao Y; Zhang G; Wang P; Zhou J; Gan W; Song Y; Huang L; Zhang Y; Luo G; Gong J; Zhang L
    BMC Gastroenterol; 2017 Jan; 17(1):2. PubMed ID: 28056823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TS, RRM1, ERCC1, TUBB3 and STMN1 Genes in Tissues of Non-small Cell Lung Cancer and its Significance in Guiding Postoperative Adjuvant Chemotherapy.
    Zou ZQ; Du YY; Sui G; Xu SN
    Asian Pac J Cancer Prev; 2015; 16(8):3189-94. PubMed ID: 25921119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
    Ma W; Li W; Gao M; Li XN
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer.
    Han Y; Yu DP; Zhou SJ; Song XY; Li YS; Xiao N; Liu ZD; Sun XJ; Zhao QY; Liu SK
    Genet Mol Res; 2014 Oct; 13(4):8913-24. PubMed ID: 25366782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
    Qian XP; Liu BR; Shi MQ; Liu XZ; Hu WJ; Zou ZY; Wei J
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):33-7. PubMed ID: 19538866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [EGFR gene copy number, ERCC1 and BRCA1 protein expression and their relationship in non-small cell lung cancer].
    Deng QH; Qiu Y; Mo MC; Zhang X; Xiong XG; Jiang M; He P; Wen DP; Zheng GX; He JX
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):508-12. PubMed ID: 22093627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.
    Friboulet L; Barrios-Gonzales D; Commo F; Olaussen KA; Vagner S; Adam J; Goubar A; Dorvault N; Lazar V; Job B; Besse B; Validire P; Girard P; Lacroix L; Hasmats J; Dufour F; André F; Soria JC
    Clin Cancer Res; 2011 Sep; 17(17):5562-72. PubMed ID: 21750204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
    Han Y; Wang XB; Xiao N; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(5):2987-90. PubMed ID: 23803067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of ERCC1, RRM1, TOP1, TOP2A, TYMS, TUBB3, GSTP1 AND BRCA1 mRNA expressions in patients with non-small-cell lung cancer receiving a platinum-based chemotherapy.
    M Tsyganov M; O Rodionov E; M Pevzner A; K Ibragimova M; V Miller S; V Cheremisina O; G Frolova I; A Tuzikov S; V Litviakov N
    J BUON; 2020; 25(4):1728-1736. PubMed ID: 33099907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors.
    Monica V; Familiari U; Chiusa L; Rossi G; Novero D; Busso S; Ruffini E; Ardissone F; Scagliotti GV; Papotti M
    Lung Cancer; 2013 Mar; 79(3):228-35. PubMed ID: 23276504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between epidermal growth factor receptor gene copy number and ERCC1, BRCA1 protein expression in Chinese patients with non-small cell lung cancer.
    Zhang Y; Yang H; Qiu Y; Deng Q; Liu J; Zhao M; He P; Mo M; Zou X; He J
    Med Oncol; 2014 Mar; 31(3):803. PubMed ID: 24452282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients.
    Yu D; Li J; Han Y; Liu S; Xiao N; Li Y; Sun X; Liu Z
    Chin Med J (Engl); 2014; 127(8):1464-8. PubMed ID: 24762590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
    Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
    Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ERCC1 expression and outcomes of neo-adjuvant chemotherapy in elderly patients with non-small cell lung cancer].
    Li GF; Deng SJ; Weng WW; Guo G; Chen N
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2131-3. PubMed ID: 20855270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy.
    Das M; Riess JW; Frankel P; Schwartz E; Bennis R; Hsieh HB; Liu X; Ly JC; Zhou L; Nieva JJ; Wakelee HA; Bruce RH
    Lung Cancer; 2012 Aug; 77(2):421-6. PubMed ID: 22555222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of TOP2A gene aberrations and expression of topoisomerase IIα protein and TOP2A mRNA expression in primary breast cancer: a retrospective study of 86 cases using fluorescence in situ hybridization and immunohistochemistry.
    Meng H; Chen R; Li W; Xu L; Xu L
    Pathol Int; 2012 Jun; 62(6):391-9. PubMed ID: 22612507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A; Sørensen JB
    Lung Cancer; 2009 May; 64(2):131-9. PubMed ID: 18804893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.